Cover Image
市場調查報告書

Bolder Biotechnology, Inc.的產品平台分析

Bolder Biotechnology, Inc. - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品編碼 253705
出版日期 內容資訊 英文 29 Pages
訂單完成後即時交付
價格
Back to Top
Bolder Biotechnology, Inc.的產品平台分析 Bolder Biotechnology, Inc. - Product Pipeline Review - 2016
出版日期: 2016年02月24日 內容資訊: 英文 29 Pages
簡介

Bolder Biotechnology, Inc.是總公司設在美國的製藥企業,提供生長激素,β干擾素,伽馬干擾素,促血紅細胞生長素,長時作用型EPO,α干擾素等專利人類用蛋白質性醫藥品。該公司產品對血液疾病、內分泌疾病、感染疾病、癌症等疾病的效果值得期待。

本報告提供Bolder Biotechnology, Inc. 的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

目錄

Bolder Biotechnology, Inc. 的基本資料

  • Bolder Biotechnology, Inc. 概要
  • 主要資訊
  • 企業資料

Bolder Biotechnology, Inc. :R&D概要

  • 主要的治療範圍

Bolder Biotechnology, Inc. :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 聯合治療模式
  • 合作夥伴產品
  • 轉出授權產品

Bolder Biotechnology, Inc. :開發中產品概況

  • 初期階段的開發中產品
    • 在前臨床階段的產品/聯合治療模式
    • 藥物研發階段的產品/聯合治療模式

Bolder Biotechnology, Inc.:藥物簡介

  • BBT-007
  • BBT-009
  • BBT-015
  • BBT-018
  • BBT-021
  • BBT-030
  • BBT-031
  • BBT-032
  • BBT-045
  • BBT-046
  • BBT-012

Bolder Biotechnology, Inc. :開發平台分析

  • 各標靶
  • 各分子類型
  • 各作用機制

Bolder Biotechnology, Inc. :最新的開發平台資訊

Bolder Biotechnology, Inc. :開發暫停中的計劃

Bolder Biotechnology, Inc. :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07954CDB

Summary

Global Markets Direct's, 'Bolder Biotechnology, Inc. - Product Pipeline Review - 2016', provides an overview of the Bolder Biotechnology, Inc.'s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Bolder Biotechnology, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Bolder Biotechnology, Inc.
  • The report provides overview of Bolder Biotechnology, Inc. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Bolder Biotechnology, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Bolder Biotechnology, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate Bolder Biotechnology, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Bolder Biotechnology, Inc.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Bolder Biotechnology, Inc.'s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Bolder Biotechnology, Inc. Snapshot
    • Bolder Biotechnology, Inc. Overview
    • Key Information
    • Key Facts
  • Bolder Biotechnology, Inc. - Research and Development Overview
  • Key Therapeutic Areas
  • Bolder Biotechnology, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Bolder Biotechnology, Inc. - Pipeline Products Glance
  • Bolder Biotechnology, Inc. - Early Stage Pipeline Products
  • Preclinical Products/Combination Treatment Modalities
  • Discovery Products/Combination Treatment Modalities
  • Bolder Biotechnology, Inc. - Drug Profiles
    • BBT-007
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BBT-009
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BBT-015
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BBT-018
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BBT-021
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BBT-031
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BBT-032
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BBT-046
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BBT-059
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BBT-012
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Bolder Biotechnology, Inc. - Pipeline Analysis
    • Bolder Biotechnology, Inc. - Pipeline Products by Target
    • Bolder Biotechnology, Inc. - Pipeline Products by Molecule Type
    • Bolder Biotechnology, Inc. - Pipeline Products by Mechanism of Action
  • Bolder Biotechnology, Inc. - Dormant Projects
  • Bolder Biotechnology, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Bolder Biotechnology, Inc., Key Information
  • Bolder Biotechnology, Inc., Key Facts
  • Bolder Biotechnology, Inc. - Pipeline by Indication, 2016
  • Bolder Biotechnology, Inc. - Pipeline by Stage of Development, 2016
  • Bolder Biotechnology, Inc. - Monotherapy Products in Pipeline, 2016
  • Bolder Biotechnology, Inc. - Preclinical, 2016
  • Bolder Biotechnology, Inc. - Discovery, 2016
  • Bolder Biotechnology, Inc. - Pipeline by Target, 2016
  • Bolder Biotechnology, Inc. - Pipeline by Molecule Type, 2016
  • Bolder Biotechnology, Inc. - Pipeline Products by Mechanism of Action, 2016
  • Bolder Biotechnology, Inc. - Dormant Developmental Projects,2016

List of Figures

  • Bolder Biotechnology, Inc. - Pipeline by Top 10 Indication, 2016
  • Bolder Biotechnology, Inc. - Pipeline by Stage of Development, 2016
  • Bolder Biotechnology, Inc. - Monotherapy Products in Pipeline, 2016
  • Bolder Biotechnology, Inc. - Pipeline by Target, 2016
  • Bolder Biotechnology, Inc. - Pipeline by Molecule Type, 2016
  • Bolder Biotechnology, Inc. - Pipeline Products by Mechanism of Action, 2016
Back to Top